ModernMedicine Resource Center More Topics

Video

New Anticoagulants for AF

Results of a new meta-analysis indicate that for patients with atrial fibrilation, treatment with one of the new oral anticoagulants rather than warfarin is more effective for preventing stroke and less risky in terms of intracranial bleeding.

New Oral Anti-Coagulants

Can dabigatran be used in pregnant women?
Can dabigatran be used in pregnant women?Using dabigatran anticoagulation treatment for pregnant women could potentially affect fetal blood coagulation, according to a study published in Obstetrics & Gynecology. Dabigatran may cross the placenta to the fetus.
Apixaban cuts stroke risk regardless of BP control
Apixaban cuts stroke risk regardless of BP controlA subanalysis of the Phase 3 ARISTOTLE trial indicates that apixaban reduces the risk of stroke regardless of whether a patient’s blood pressure is controlled.
New oral anticoagulants increase risk for GI bleeding
New oral anticoagulants increase risk for GI bleedingPatients taking the new generation of oral anticoagulants are associated with a significantly higher risk of gastrointestinal bleeding, according to a study published in the July 2013 issue of Gastroenterology.

Advertisement

Anticoagulant dosing in obesity should be individualized and drug-specific
Anticoagulant dosing in obesity should be individualized and drug-specific
Cardiologists prescribing rivaroxaban more than warfarin
Cardiologists prescribing rivaroxaban more than warfarinCardiologists are increasingly bypassing the anticoagulant warfarin in favor of rivaroxaban, a more-expensive alternative with fewer side effects, according to the IMS NPA Weekly.
First study of patient satisfaction with a pharmacy program released by Henry Ford Hospital
First study of patient satisfaction with a pharmacy program released by Henry Ford HospitalPatient satisfaction improves under PDAS model

Advertisement

Anticoagulant use predicts survival in metastatic prostate cancerAnticoagulation while on docetaxel (Taxotere) chemotherapy is an independent predictor of survival in men with metastatic castration-resistant prostate cancer (mCRPC).
Web-based program aids clinicians in anticoagulation treatment
Web-based program aids clinicians in anticoagulation treatmentA new web-based program aims to help clinical pharmacists and other healthcare professionals achieve the best possible outcomes for their patients on antithrombotic medications.
Rivaroxaban has more indications
Rivaroxaban has more indicationsThe FDA has increased the indications for rivaroxaban. Patients with stents who receive oral anticoagulants do not need aspirin. Low-dose aspiring has shown some ability to reduce venous thromboembolism.

Advertisement

Advertisement